ORMD-0801 8 mg
ORA-D-013-3
Phase 3 small_molecule active
Quick answer
ORMD-0801 8 mg for Type 2 Diabetes Mellitus is a Phase 3 program (small_molecule) at ORAMED PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ORAMED PHARMACEUTICALS INC.
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active